123 related articles for article (PubMed ID: 18275098)
1. Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides.
Park KH; Park Y; Park IS; Hahm KS; Shin SY
J Pept Sci; 2008 Jul; 14(7):876-82. PubMed ID: 18275098
[TBL] [Abstract][Full Text] [Related]
2. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
4. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
Nan YH; Bang JK; Shin SY
Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
[TBL] [Abstract][Full Text] [Related]
5. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
[TBL] [Abstract][Full Text] [Related]
6. The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide.
Lim SS; Kim Y; Park Y; Kim JI; Park IS; Hahm KS; Shin SY
Biochem Biophys Res Commun; 2005 Sep; 334(4):1329-35. PubMed ID: 16040002
[TBL] [Abstract][Full Text] [Related]
7. Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action.
Yang ST; Lee JY; Kim HJ; Eu YJ; Shin SY; Hahm KS; Kim JI
FEBS J; 2006 Sep; 273(17):4040-54. PubMed ID: 16889633
[TBL] [Abstract][Full Text] [Related]
8. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides.
Park KH; Nan YH; Park Y; Kim JI; Park IS; Hahm KS; Shin SY
Biochim Biophys Acta; 2009 May; 1788(5):1193-203. PubMed ID: 19285481
[TBL] [Abstract][Full Text] [Related]
9. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1.
Wang P; Bang JK; Kim HJ; Kim JK; Kim Y; Shin SY
Peptides; 2009 Dec; 30(12):2144-9. PubMed ID: 19778562
[TBL] [Abstract][Full Text] [Related]
11. Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.
Zhu WL; Shin SY
J Pept Sci; 2009 May; 15(5):345-52. PubMed ID: 19206074
[TBL] [Abstract][Full Text] [Related]
12. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.
Zhu WL; Lan H; Park IS; Kim JI; Jin HZ; Hahm KS; Shin SY
Biochem Biophys Res Commun; 2006 Oct; 349(2):769-74. PubMed ID: 16945333
[TBL] [Abstract][Full Text] [Related]
13. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action.
Shin S; Kim JK; Lee JY; Jung KW; Hwang JS; Lee J; Lee DG; Kim I; Shin SY; Kim Y
J Pept Sci; 2009 Sep; 15(9):559-68. PubMed ID: 19598182
[TBL] [Abstract][Full Text] [Related]
14. Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2007 Aug; 13(8):529-35. PubMed ID: 17604338
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cationic antimicrobial peptides with phospholipid vesicles and their antibacterial activity.
Chou HT; Wen HW; Kuo TY; Lin CC; Chen WJ
Peptides; 2010 Oct; 31(10):1811-20. PubMed ID: 20600422
[TBL] [Abstract][Full Text] [Related]
16. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide.
Malina A; Shai Y
Biochem J; 2005 Sep; 390(Pt 3):695-702. PubMed ID: 15907192
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin.
Staubitz P; Peschel A; Nieuwenhuizen WF; Otto M; Götz F; Jung G; Jack RW
J Pept Sci; 2001 Oct; 7(10):552-64. PubMed ID: 11695650
[TBL] [Abstract][Full Text] [Related]
19. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
[TBL] [Abstract][Full Text] [Related]
20. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
Glukhov E; Burrows LL; Deber CM
Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
